J Robert Kerrey Sells 5,638 Shares of Tenet Healthcare (NYSE:THC) Stock

Tenet Healthcare Corporation (NYSE:THC) Director J Robert Kerrey sold 5,638 shares of the stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $174.52, for a total transaction of $983,943.76. Following the sale, the director owned 16,804 shares in the company, valued at approximately $2,932,634.08. This trade represents a 25.12% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Tenet Healthcare Price Performance

THC opened at $174.83 on Friday. The firm has a market cap of $15.06 billion, a price-to-earnings ratio of 9.09, a price-to-earnings-growth ratio of 1.15 and a beta of 1.30. Tenet Healthcare Corporation has a fifty-two week low of $146.60 and a fifty-two week high of $247.21. The company’s 50-day moving average price is $189.94 and its 200 day moving average price is $201.87. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings data on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, topping the consensus estimate of $4.21 by $0.61. The firm had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.39 billion. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. Tenet Healthcare’s quarterly revenue was up 2.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $4.36 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, sell-side analysts expect that Tenet Healthcare Corporation will post 17.67 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Wedmont Private Capital grew its position in Tenet Healthcare by 2.5% in the fourth quarter. Wedmont Private Capital now owns 2,088 shares of the company’s stock worth $422,000 after buying an additional 50 shares during the last quarter. Baron Wealth Management LLC grew its position in Tenet Healthcare by 4.8% in the fourth quarter. Baron Wealth Management LLC now owns 1,142 shares of the company’s stock worth $227,000 after buying an additional 52 shares during the last quarter. PeakShares LLC grew its position in Tenet Healthcare by 3.3% in the first quarter. PeakShares LLC now owns 1,693 shares of the company’s stock worth $319,000 after buying an additional 54 shares during the last quarter. Sagespring Wealth Partners LLC boosted its stake in Tenet Healthcare by 3.6% in the 4th quarter. Sagespring Wealth Partners LLC now owns 1,573 shares of the company’s stock worth $313,000 after purchasing an additional 55 shares during the period. Finally, Sanctuary Advisors LLC boosted its stake in Tenet Healthcare by 0.5% in the 1st quarter. Sanctuary Advisors LLC now owns 11,900 shares of the company’s stock worth $2,246,000 after purchasing an additional 57 shares during the period. Institutional investors and hedge funds own 95.44% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have commented on THC shares. Stephens dropped their price target on shares of Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating on the stock in a research note on Monday, May 4th. Cantor Fitzgerald restated an “overweight” rating on shares of Tenet Healthcare in a research note on Wednesday, March 4th. Barclays dropped their price target on shares of Tenet Healthcare from $257.00 to $238.00 and set an “overweight” rating on the stock in a research note on Tuesday, May 5th. KeyCorp dropped their price target on shares of Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating on the stock in a research note on Friday, May 1st. Finally, Jefferies Financial Group raised their price objective on shares of Tenet Healthcare from $250.00 to $265.00 and gave the company a “buy” rating in a research note on Thursday, February 12th. Nineteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, Tenet Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $244.16.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.